Skype

Tianjin New Bay Bioresearch Co., Ltd.


Contact: Rodrigo Berlie
Address: 3 Jian She Road, Ba Li Tai, Industry Area, Jin Nan, District, Tianjin 300350, China
Phone: +86-(22)-28751515 | Map/Directions >>
 
 

Profile: Tianjin New Bay Bioresearch Co., manufactures glucose pilot blood monitoring systems. We provide phencyclidine enzyme immunoassay, propoxyphene enzyme immunoassay, tricyclic antidepressant drugs radioimmunoassay, cannabinoids enzyme immunoassay tests and HCG over the counter pregnancy test kits.

FDA Registration Number: 3004561580
US Agent: Roger De Bock / Sdbiotek
Phone: +1-(619)-994-1417  E-Mail:

20 Products/Services (Click for related suppliers)  
• Amphetamine Enzyme Immunoassay Test (FDA Code: DKZ / 862.3100)
An amphetamine test system is a device intended to measure amphetamine, a central nervous system stimulating drug, in plasma and urine. Measurements obtained by this device are used in the diagnosis and treatment of amphetamine use or overdose and in monitoring levels of amphetamine to ensure appropriate therapy.
• Assayed and Unassayed Single (Specified) Analyte Controls (FDA Code: JJX / 862.1660)
A quality control material (assayed and unassayed) for clinical chemistry is a device intended for medical purposes for use in a test system to estimate test precision and to detect systematic analytical deviations that may arise from reagent or analytical instrument variation. A quality control material (assayed and unassayed) may be used for proficiency testing in interlaboratory surveys. This generic type of device includes controls (assayed and unassayed) for blood gases, electrolytes, enzymes, multianalytes (all kinds), single (specified) analytes, or urinalysis controls.
• Barbiturate Enzyme Immunoassay Test (FDA Code: DIS / 862.3150)
A barbiturate test system is a device intended to measure barbiturates, a class of hypnotic and sedative drugs, in serum, urine, and gastric contents. Measurements obtained by this device are used in the diagnosis and treatment of barbiturate use or overdose and in monitoring levels of barbiturate to ensure appropriate therapy.
• Benzodiazepine Enzyme Immunoassay Test (FDA Code: JXM / 862.3170)
A benzodiazepine test system is a device intended to measure any of the benzodiazepine compounds, sedative and hypnotic drugs, in blood, plasma, and urine. The benzodiazepine compounds include chlordiazepoxide, diazepam, oxazepam, chlorzepate, flurazepam, and nitrazepam. Measurements obtained by this device are used in the diagnosis and treatment of benzodiazepine use or overdose and in monitoring levels of benzodiazepines to ensure appropriate therapy.
• Cannabinoids Enzyme Immunoassay Test (FDA Code: LDJ / 862.3870)
A cannabinoid test system is a device intended to measure any of the cannabinoids, hallucinogenic compounds endogenous to marihuana, in serum, plasma, saliva, and urine. Cannabinoid compounds includedelta -9-tetrahydrocannabinol, cannabidiol, cannabinol, and cannabichromene. Measurements obtained by this device are used in the diagnosis and treatment of cannabinoid use or abuse and in monitoring levels of cannabinoids during clinical investigational use.
• Cocaine and Cocaine Metabolites Enzyme Immunoassay Test (FDA Code: DIO / 862.3250)
A cocaine and cocaine metabolite test system is a device intended to measure cocaine and a cocaine metabolite (benzoylecgonine) in serum, plasma, and urine. Measurements obtained by this device are used in the diagnosis and treatment of cocaine use or overdose.
• Glucose Oxidase, Glucose (FDA Code: CGA / 862.1345)
A glucose test system is a device intended to measure glucose quantitatively in blood and other body fluids. Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma.
• HCG Over The Counter Pregnancy Test Kit (FDA Code: LCX / 862.1155)
A human chorionic gonadotropin (HCG) test system is a device intended for the early detection of pregnancy is intended to measure HCG, a placental hormone, in plasma or urine.
• Luteinizing Hormone Radioimmunoassay (FDA Code: CEP / 862.1485)
A luteinizing hormone test system is a device intended to measure luteinizing hormone in serum and urine. Luteinizing hormone measurements are used in the diagnosis and treatment of gonadal dysfunction.
• Metamphetamine Thin Layer Chromatography Test (FDA Code: DJC / 862.3610)
A methamphetamine test system is a device intended to measure methamphetamine, a central nervous system stimulating drug, in serum, plasma, and urine. Measurements obtained by this device are used in the diagnosis and treatment of methamphetamine use or overdose.
• Methadone Enzyme Immunoassay Test (FDA Code: DJR / 862.3620)
A methadone test system is a device intended to measure methadone, an addictive narcotic pain-relieving drug, in serum and urine. Measurements obtained by this device are used in the diagnosis and treatment of methadone use or overdose and to determine compliance with regulations in methadone maintenance treatment.
• Occult Blood Reagent (FDA Code: KHE / 864.6550)
An occult blood test is a device used to detect occult blood in urine or feces. (Occult blood is blood present in such small quantities that it can be detected only by chemical tests of suspected material, or by microscopic or spectroscopic examination.)
• Opiates Enzyme Immunoassay Test (FDA Code: DJG / 862.3650)
An opiate test system is a device intended to measure any of the addictive narcotic pain-relieving opiate drugs in blood, serum, urine, gastric contents, and saliva. An opiate is any natural or synthetic drug that has morphine-like pharmocological actions. The opiates include drugs such as morphine, morphine glucoronide, heroin, codeine, nalorphine, and meperedine. Measurements obtained by this device are used in the diagnosis and treatment of opiate use or overdose and in monitoring the levels of opiate administration to ensure appropriate therapy.
• Over-The-Counter Blood Glucose Test System (FDA Code: NBW / 862.1345)
• Phencyclidine Enzyme Immunoassay (FDA Code: LCM)
• Propoxyphene Enzyme Immunoassay (FDA Code: JXN / 862.3700)
A propoxyphene test system is a device intended to measure propoxyphene, a pain-relieving drug, in serum, plasma, and urine. Measurements obtained by this device are used in the diagnosis and treatment of propoxyphene use or overdose or in monitoring levels of propoxyphene to ensure appropriate therapy.
• Streptococcus Spp Antiserum (FDA Code: GTZ / 866.3740)
• Tricyclic Antidepressant Drugs Radioimmunoassay Test (FDA Code: LFG / 862.3910)
A tricyclic antidepressant drugs test system is a device intended to measure any of the tricyclic antidepressant drugs in serum. The tricyclic antidepressant drugs include imipramine, desipramine, amitriptyline, nortriptyline, protriptyline, and doxepin. Measurements obtained by this device are used in the diagnosis and treatment of chronic depression to ensure appropriate therapy.
• Tricyclic Antidepressant Drugs U.V. Spectrometry (FDA Code: LFH / 862.3910)
• U.V Light (FDA Code: DJS / 862.2270)
A thin-layer chromatography (TLC) system for clinical use is a device intended to separate one or more drugs or compounds from a mixture. The mixture of compounds is absorbed onto a stationary phase or thin layer of inert material (e.g., cellulose, alumina, etc.) and eluted off by a moving solvent (moving phase) until equilibrium occurs between the two phases.

 Edit or Enhance this Company (609 potential buyers viewed listing)
Browse Category   |   Alphabetical Products   |   ALL 25,000 Suppliers
HomeBuyAdd FREE ListingAdvertise Medical CompanyMedical Portal